Kexing vaccine is developed by Beijing Kexing Bio-pharmaceutical Co., Ltd., which is free for everyone in China, but not abroad, and the price of Kexing vaccine exported abroad is higher. But thanks to the concern of the party and the state for the broad masses of the people in our country, we can get the vaccine for free.
Everyone must have this question in mind: all the vaccines we vaccinate are free of charge, and some even send money or gifts (such as rice flour oil) to the vaccinated countries. Why? We can get the vaccine for free, whether it is free or not. In other words, someone pays for our vaccine. So who will pay the bill? Our country, of course. Even the government encourages us to vaccinate not only for free, but also occasionally gives us some encouragement. Are we just proud and happy because we grew up in such a country? This is the so-called friend in need!
The state pays the bill, and Kexing Biopharmaceutical has no loss. On the other hand, the export of Kexing vaccine abroad is really a penny for a penny. It's not cheap at all. It's more expensive than other vaccines. It is reported that Brazil bought 1 100 million Kexing vaccines from China before, and the price of each vaccine was about 70 RMB. This is just Brazil, as well as India, Japan and other countries. However, China's Kexing vaccine is still in short supply abroad, so many people buy it abnormally, and the price is unimaginable! Therefore, it is understandable that Kexing vaccine can get 50 billion yuan in revenue.
Although COVID-19 vaccination in China is free, it is an opportunity for enterprises. The reason is that the free money comes from the government, the enterprises, and the vaccines are sold to the country to meet the vaccination needs.
In fact, in the COVID-19 epidemic, some pharmaceutical enterprises did get development opportunities, and their income and profits rose sharply. In particular, vaccine manufacturers are in short supply, which makes them make huge profits. Kexing is one of the most important enterprises and one of the enterprises that benefit the most.
This also shows from one side that enterprises can have more prospects and development potential as long as they attach importance to technological innovation and new drug development. This time, the enterprises that can develop COVID-19 vaccine seized the opportunity of development, and also got the opportunity of development. On the contrary, those companies that only produce generic drugs lag behind others, or even fail to produce generic drugs, and their profits can only be relatively low.
On the other hand, each of us should really be grateful for this new era. Look at the epidemic situation abroad, it is completely politicized, wearing masks will rise to the height of freedom, and vaccination will also produce drug resistance. To tell the truth, our great victory in fighting the epidemic cannot be achieved without the strong leadership of the CPC Central Committee, the cooperation and support of all the people, and the strong organizational force, cohesion and action of our socialism. These are the fundamental guarantee for us to realize the Chinese dream of great rejuvenation of the Chinese nation.
Although there is no large-scale rebound in China, sporadic and gradual regional emergence will also affect the overall situation, and your epidemic prevention measures cannot be weakened.